These factors prompted research into better and more permanent treatments for T1D. The most ... furthers the need for immune suppression to prevent the transplants from being rejected. In Deng’s ...

Engineering of a novel device to treat T1D, featuring local immunosuppression and a vascularized ... caused similar amounts of vascularization and limited immune cell infiltration within the device.

Islet autoimmunity signals the first sign of self-damage of the pancreas, a hallmark of T1D," says Dr. Kim. Researchers say ...

The identification of diabetes-relevant islet autoantibodies is essential for predicting and preventing type 1 diabetes (T1D). The aim of the current study was to evaluate a newly developed ...

These diseases have the same underlying manifestation – namely that the immune system is inappropriately responding to self-tissues such as the joint (RA), the kidney (SLE), the nervous system (MS) or ...

suggesting that even for complex diseases such as T1D, induction of immune tolerance is possible. In a mouse model of multiple sclerosis (MS), administration of TPCs both prior to disease ...

Dr. Bryce Carey will be presenting this seminar. Type 1 diabetes (T1D) is a lifelong disease caused by the autoimmune destruction of insulin-producing islet cells (beta cells) in the pancreas. Insulin ...